131 related articles for article (PubMed ID: 18841002)
1. Efalizumab rebound response to a sequential therapy of infliximab followed by efalizumab.
Brunasso AM; Delfino C; Massone C
Dermatology; 2009; 218(1):73-4. PubMed ID: 18841002
[No Abstract] [Full Text] [Related]
2. Sequential therapy in plaque psoriasis using the " Hit and Run " approach: infliximab followed by efalizumab.
Penz S; Pelletier F; Riou-Gotta MO; Puzenat E; Levang J; Mermet I; Humbert P; Aubin F
Int J Dermatol; 2012 Feb; 51(2):236-7. PubMed ID: 22250639
[No Abstract] [Full Text] [Related]
3. Rebound of psoriasis after efalizumab discontinuation, despite being on high-dose cyclosporine.
Maskatia ZK; Koo J
J Drugs Dermatol; 2007 Sep; 6(9):941-4. PubMed ID: 17941368
[TBL] [Abstract][Full Text] [Related]
4. Use of infliximab in the treatment of psoriasis.
Lee MR; Cooper AJ
Australas J Dermatol; 2004 Aug; 45(3):193-5. PubMed ID: 15250904
[No Abstract] [Full Text] [Related]
5. Infliximab-induced remission of extensive plaque psoriasis.
Amital H; Ingber A; Rubinow A
Isr Med Assoc J; 2003 Nov; 5(11):827-8. PubMed ID: 14650114
[No Abstract] [Full Text] [Related]
6. Treatment of inverse psoriasis with efalizumab.
George D; Rosen T
J Drugs Dermatol; 2009 Jan; 8(1):74-6. PubMed ID: 19180901
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of recalcitrant palmoplantar pustular psoriasis with sequential use of infliximab and adalimumab.
Yawalkar N; Hunger RE
Dermatology; 2009; 218(1):79-83. PubMed ID: 18974629
[No Abstract] [Full Text] [Related]
8. Childhood generalized pustular psoriasis: longtime remission with combined infliximab and methotrexate treatment.
Skrabl-Baumgartner A; Weger W; Salmhofer W; Jahnel J
Pediatr Dermatol; 2015; 32(1):e13-4. PubMed ID: 25644044
[TBL] [Abstract][Full Text] [Related]
9. Infliximab- and methotrexate-resistant rebound of psoriasis after discontinuation of efalizumab (Raptiva).
Thielen AM; Barde C; Saurat JH
Br J Dermatol; 2006 Oct; 155(4):846-7. PubMed ID: 16965444
[No Abstract] [Full Text] [Related]
10. Infliximab then efalizumab, the 'hit and run' approach does not work.
Barde C; Thielen AM; Saurat JH
Dermatology; 2008; 216(2):171-2. PubMed ID: 18216482
[TBL] [Abstract][Full Text] [Related]
11. Re-induction as a possible alternative modality of dose escalation of infliximab: a prospective evaluation in a small series of psoriatic patients.
Cassano N; Puglisi Guerra A; Malara C; Loconsole F; Galluccio A; Pezza M; Vena GA
Int J Immunopathol Pharmacol; 2007; 20(3):647-50. PubMed ID: 17880779
[TBL] [Abstract][Full Text] [Related]
12. Long-term durability and dose escalation patterns in infliximab therapy for psoriasis.
Luber AJ; Tsui CL; Heinecke GM; Lebwohl MG; Levitt JO
J Am Acad Dermatol; 2014 Mar; 70(3):525-32. PubMed ID: 24388425
[TBL] [Abstract][Full Text] [Related]
13. Infliximab rescue of efalizumab withdrawal flare and psoriasis-precipitated depression.
Yip L; Harrison S; Foley P
Australas J Dermatol; 2008 Nov; 49(4):250-1. PubMed ID: 18855796
[No Abstract] [Full Text] [Related]
14. Addition of low-dose methotrexate to infliximab in the treatment of a patient with severe, recalcitrant pustular psoriasis.
Barland C; Kerdel FA
Arch Dermatol; 2003 Jul; 139(7):949-50. PubMed ID: 12873907
[No Abstract] [Full Text] [Related]
15. Palmoplantar pustular psoriasis: successful therapy with efalizumab after non-response to infliximab.
Wozel G; Vitéz L; Meurer M
Acta Dermatovenerol Alp Pannonica Adriat; 2008 Sep; 17(3):133-6. PubMed ID: 18853077
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of severe recalcitrant psoriasis with combination infliximab and methotrexate.
Kirby B; Marsland AM; Carmichael AJ; Griffiths CE
Clin Exp Dermatol; 2001 Jan; 26(1):27-9. PubMed ID: 11260172
[TBL] [Abstract][Full Text] [Related]
17. Transitioning patients from efalizumab to alternative psoriasis therapies: findings from an open-label, multicenter, Phase IIIb study.
Menter A; Hamilton TK; Toth DP; Leung HM; Wetherill G; Hennessey B; Garovoy M; Kwon P; Pariser DM;
Int J Dermatol; 2007 Jun; 46(6):637-48. PubMed ID: 17550570
[TBL] [Abstract][Full Text] [Related]
18. [Biologics in the treatment of psoriasis].
Dissemond J; Grabbe S
MMW Fortschr Med; 2006 Sep; 148(38):42-4. PubMed ID: 17036963
[TBL] [Abstract][Full Text] [Related]
19. [Our experience with infliximab in reclacitrant cases of psoriasis].
Pereiro M; González-Vilas D; Sánchez-Aguilar D; Toribio J
Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():43-7. PubMed ID: 19080991
[TBL] [Abstract][Full Text] [Related]
20. Striking and rapid improvement of plaque psoriasis with infliximab. A report of two cases.
Al-Salem IH
Dermatology; 2003; 207(1):54-6. PubMed ID: 12835550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
